The third ban of "mad cow disease" issued by the State Food and Drug Administration

Introduction: the State Food and Drug Administration issued a third ban on mad cow disease on July 15, in order to strengthen the supervision and management of bovine origin and related drugs, and ensure the safety of clinical medication The State Food and Drug Administration said to the author that from now on, it is forbidden to use imported cattle derived materials to prepare Chinese patent medicines, such as natural bezoar, cattle gall cream, cattle bone powder, etc.; it is forbidden to use gelatin prepared from cattle bone in countries with BSE epidemic as raw materials for drug production raw materials, auxiliary materials, shaping agents and hollow capsules Since then, the State Food and drug administration has suspended the acceptance of new bovine drugs and the application for the registration certificate of imported drugs for blood products made from human plasma of countries with BSE epidemic, the person said When applying for import drug registration certificate for blood products produced abroad, other biological products using human albumin as stabilizer and protectant, or blood products having obtained import drug registration certificate, the official certification document that the blood product preparation raw material plasma comes from the country without BSE epidemic situation must be provided For the manufacturers of bio extracted drugs, bio products, blood products, Chinese patent medicines and other varieties that have obtained the import drug registration certificate, the State Food and drug administration requires them to, before October 1 this year, use the raw materials, excipients and dosage forms that do not use the bovine materials for drugs, or use the bovine materials and human plasma from those that do not have the epidemic situation of mad cow disease The official documents of the State shall be submitted to the State Food and Drug Administration for the record It is understood that in order to prevent the spread of "mad cow disease" through drug use, the State Food and Drug Administration issued a notice successively in 2000 and 2001 to make clear the relevant issues By the end of April this year, "mad cow disease" had occurred in the Netherlands, Denmark, Germany, Luxembourg, Belgium, Spain, Ireland, the United Kingdom, Austria, Portugal, Italy, France, Finland, Greece, the Czech Republic, Slovakia, Liechtenstein, Switzerland, Japan and Oman, the person from the State Food and Drug Administration said.